Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Omission of axillary dissection in women with breast cancer and one or two positive sentinel-node biopsy is a major advancement in the management of this disease. Supported by a sound rationale and confirmed by prospective, randomized trials, omission of axillary dissection is now recommended in women who have undergone breast conserving surgery and who are candidate to adjuvant radiotherapy. Because breast cancer is best managed in the context of a multidisciplinary team, this surgical shift in the paradigm is expected to have implications that extend also to the other specialties involved in the team.In fact, the full evaluation of the axillary tumor burden has been historically considered an essential part of tumor staging and the absolute number of involved node critical information to tailor post-surgical treatments. Lack of this information in a patient with axillary involvement documented by a positive sentinel lymph-node biopsy may represent a challenge when deciding on further, post-surgical treatments. This review will address the critical aspects and the potential implications of omission of axillary dissection in the context of the multidisciplinary breast team.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalCancer Treatment Reviews
Volume48
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Dissection
Breast Neoplasms
Sentinel Lymph Node Biopsy
Adjuvant Radiotherapy
Segmental Mastectomy
Neoplasm Staging
Disease Management
Tumor Burden
Breast
Therapeutics
Biopsy
Sentinel Lymph Node
cyhalothrin

Keywords

  • Breast cancer
  • Chemotherapy
  • Multidisciplinary breast team
  • Prognosis
  • Radiotherapy
  • Sentinel lymph-node biopsy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

@article{b2c1e9923ed84ffca47363f0aa5ffadd,
title = "Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer",
abstract = "Omission of axillary dissection in women with breast cancer and one or two positive sentinel-node biopsy is a major advancement in the management of this disease. Supported by a sound rationale and confirmed by prospective, randomized trials, omission of axillary dissection is now recommended in women who have undergone breast conserving surgery and who are candidate to adjuvant radiotherapy. Because breast cancer is best managed in the context of a multidisciplinary team, this surgical shift in the paradigm is expected to have implications that extend also to the other specialties involved in the team.In fact, the full evaluation of the axillary tumor burden has been historically considered an essential part of tumor staging and the absolute number of involved node critical information to tailor post-surgical treatments. Lack of this information in a patient with axillary involvement documented by a positive sentinel lymph-node biopsy may represent a challenge when deciding on further, post-surgical treatments. This review will address the critical aspects and the potential implications of omission of axillary dissection in the context of the multidisciplinary breast team.",
keywords = "Breast cancer, Chemotherapy, Multidisciplinary breast team, Prognosis, Radiotherapy, Sentinel lymph-node biopsy",
author = "Riccardo Ponzone and Fiorella Ruatta and Marco Gatti and Isabella Castellano and Elena Geuna and Giulia Amato and Franziska Kubatzki and Paola Sgandurra and Anna Sapino and Filippo Montemurro",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.ctrv.2016.05.005",
language = "English",
volume = "48",
pages = "1--7",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Omission of axillary dissection after a positive sentinel lymph-node

T2 - Implications in the multidisciplinary treatment of operable breast cancer

AU - Ponzone, Riccardo

AU - Ruatta, Fiorella

AU - Gatti, Marco

AU - Castellano, Isabella

AU - Geuna, Elena

AU - Amato, Giulia

AU - Kubatzki, Franziska

AU - Sgandurra, Paola

AU - Sapino, Anna

AU - Montemurro, Filippo

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Omission of axillary dissection in women with breast cancer and one or two positive sentinel-node biopsy is a major advancement in the management of this disease. Supported by a sound rationale and confirmed by prospective, randomized trials, omission of axillary dissection is now recommended in women who have undergone breast conserving surgery and who are candidate to adjuvant radiotherapy. Because breast cancer is best managed in the context of a multidisciplinary team, this surgical shift in the paradigm is expected to have implications that extend also to the other specialties involved in the team.In fact, the full evaluation of the axillary tumor burden has been historically considered an essential part of tumor staging and the absolute number of involved node critical information to tailor post-surgical treatments. Lack of this information in a patient with axillary involvement documented by a positive sentinel lymph-node biopsy may represent a challenge when deciding on further, post-surgical treatments. This review will address the critical aspects and the potential implications of omission of axillary dissection in the context of the multidisciplinary breast team.

AB - Omission of axillary dissection in women with breast cancer and one or two positive sentinel-node biopsy is a major advancement in the management of this disease. Supported by a sound rationale and confirmed by prospective, randomized trials, omission of axillary dissection is now recommended in women who have undergone breast conserving surgery and who are candidate to adjuvant radiotherapy. Because breast cancer is best managed in the context of a multidisciplinary team, this surgical shift in the paradigm is expected to have implications that extend also to the other specialties involved in the team.In fact, the full evaluation of the axillary tumor burden has been historically considered an essential part of tumor staging and the absolute number of involved node critical information to tailor post-surgical treatments. Lack of this information in a patient with axillary involvement documented by a positive sentinel lymph-node biopsy may represent a challenge when deciding on further, post-surgical treatments. This review will address the critical aspects and the potential implications of omission of axillary dissection in the context of the multidisciplinary breast team.

KW - Breast cancer

KW - Chemotherapy

KW - Multidisciplinary breast team

KW - Prognosis

KW - Radiotherapy

KW - Sentinel lymph-node biopsy

UR - http://www.scopus.com/inward/record.url?scp=84973641948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973641948&partnerID=8YFLogxK

U2 - 10.1016/j.ctrv.2016.05.005

DO - 10.1016/j.ctrv.2016.05.005

M3 - Review article

AN - SCOPUS:84973641948

VL - 48

SP - 1

EP - 7

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

ER -